Q3 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | 00 | $0 | – | 0 | – | 0.00% | – | |
| SESN | Exit | SESEN BIO, INC. | $0 | – | -4,091,591 | – | -100.00% | – |
Q2 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SESN | New | SESEN BIO, INC. | $18,903,000 | – | 4,091,591 | – | 100.00% | – |
Q4 2020
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EBIO | Exit | SESEN BIO, INC. | $0 | – | -4,841,591 | – | -100.00% | – |
Q3 2020
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CNST | Exit | CONSTELLATION PHARMACEUTICALS INC. | $0 | – | -1,401,422 | – | -92.36% | – |
Q2 2020
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CNST | New | CONSTELLATION PHARMACEUTICALS INC. | $42,113,000 | – | 1,401,422 | – | 92.36% | – |
| EBIO | New | SESEN BIO, INC. | $3,486,000 | – | 4,841,591 | – | 7.64% | – |
Q4 2019
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EBIO | Exit | SESEN BIO, INC. | $0 | – | -4,841,591 | – | -8.89% | – |
| CNST | Exit | CONSTELLATION PHARMACEUTICALS INC. | $0 | – | -3,034,083 | – | -30.76% | – |
| RYTM | Exit | RHYTHM PHARMACEUTICALS, INC. | $0 | – | -1,781,437 | – | -60.35% | – |
Q3 2019
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RYTM | Sell | RHYTHM PHARMACEUTICALS, INC. | $38,461,000 | -11.8% | 1,781,437 | -10.1% | 60.35% | +22.3% |
| ZFGN | Exit | ZAFGEN, INC. | $0 | – | -210,371 | – | -0.28% | – |
Q2 2019
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RYTM | New | RHYTHM PHARMACEUTICALS, INC. | $43,592,000 | – | 1,981,437 | – | 49.33% | – |
| CNST | New | CONSTELLATION PHARMACEUTICALS INC. | $37,259,000 | – | 3,034,083 | – | 42.17% | – |
| EBIO | New | SESEN BIO, INC. | $7,262,000 | – | 4,841,591 | – | 8.22% | – |
| ZFGN | New | ZAFGEN, INC. | $250,000 | – | 210,371 | – | 0.28% | – |
Q4 2018
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ZFGN | Exit | ZAFGEN, INC. | $0 | – | -210,371 | – | -2.04% | – |
| EBIO | Exit | SESEN BIO, INC. | $0 | – | -4,841,591 | – | -8.66% | – |
| CNST | Exit | CONSTELLATION PHARMACEUTICALS INC. | $0 | – | -3,034,083 | – | -16.98% | – |
| RYTM | Exit | RHYTHM PHARMACEUTICALS, INC. | $0 | – | -2,981,437 | – | -72.32% | – |
Q3 2018
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RYTM | Sell | RHYTHM PHARMACEUTICALS, INC. | $86,969,000 | -30.1% | 2,981,437 | -25.1% | 72.32% | -7.7% |
| CNST | New | CONSTELLATION PHARMACEUTICALS INC. | $20,419,000 | – | 3,034,083 | – | 16.98% | – |
| KALA | Exit | KALA PHARMACEUTICALS INC. | $0 | – | -1,654,425 | – | -14.31% | – |
Q2 2018
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RYTM | New | RHYTHM PHARMACEUTICALS, INC. | $124,460,000 | – | 3,981,437 | – | 78.39% | – |
| KALA | New | KALA PHARMACEUTICALS INC. | $22,715,000 | – | 1,654,425 | – | 14.31% | – |
| EBIO | New | SESEN BIO, INC. | $9,441,000 | – | 4,841,591 | – | 5.95% | – |
| ZFGN | New | ZAFGEN, INC. | $2,152,000 | – | 210,371 | – | 1.36% | – |